title: Serotonergic or Anticholinergic Toxidrome: Case Report of a 9-Year-Old Girl.
abstract: OBJECTIVE
  The aim of this study was to report an acute onset of symptoms erroneously attributed to serotonin syndrome in a child who had been given both anticholinergic and serotonergic agents.
  
  
  METHODS
  A 9-year-old girl with chronic anxiety and gastrointestinal problems was prescribed oral sertraline 6.25 mg daily, as well as hyoscyamine, ondansetron, montelukast, and a course of nitazoxanide. She was also routinely given diphenhydramine and omeprazole. Three days after increasing sertraline to 12.5 mg, she presented to the emergency department with altered mental status, hallucinations, mydriasis, tachycardia, and pyrexia. She was admitted to the pediatric intensive care unit and subsequently treated unsuccessfully for serotonin syndrome, with blurred vision and clonus persisting at discharge 4 days after admittance. Upon follow-up with her outpatient clinic, all anticholinergic agents were discontinued, and symptoms slowly resolved.
  
  
  CONCLUSIONS
  This case illustrates the importance of differential diagnosis between toxidromes and how clinical presentation can be altered by preexisting conditions as well as the use of medications that affect multiple neurotransmitter systems.
authors.affiliation: From the Rothman Center for Pediatric Neuropsychiatry-USF Health, St Petersburg, FL.
authors.forename: Diana M
authors.initials: DM
authors.lastname: Gerardi
authors.forename: Tanya K
authors.initials: TK
authors.lastname: Murphy
authors.forename: Megan
authors.initials: M
authors.lastname: Toufexis
authors.forename: Camille
authors.initials: C
authors.lastname: Hanks
mesh_terms: D064807:Anticholinergic Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D002648:Child; D018680:Cholinergic Antagonists / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D018490:Serotonin Agents / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D020280:Sertraline / Q000009:adverse effects
chemical_list: D018680:Cholinergic Antagonists; D018490:Serotonin Agents; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline